|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
87,040,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co. is engaged in developing and commercializing targeted therapies for patients with genomically-defined cancers. Co.'s main product candidate, DAY101 (tovorafenib), is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Co.'s second product candidate, pimasertib, is an oral, highly-selective small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK), a well-characterized key signaling node in the RAS/mitogen-activated protein kinase pathway.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
1,475,454 |
2,244,684 |
Total Buy Value |
$0 |
$0 |
$14,978,328 |
$24,978,318 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
3 |
4 |
Total Shares Sold |
68,748 |
284,488 |
370,354 |
1,292,455 |
Total Sell Value |
$1,009,356 |
$4,598,978 |
$5,897,036 |
$12,396,555 |
Total People Sold |
4 |
5 |
5 |
7 |
Total Sell Transactions |
6 |
20 |
31 |
73 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Blavatnik Len |
Affiliate of 10% Owner |
|
2022-01-20 |
4 |
B |
$14.73 |
$67,976 |
D/D |
4,615 |
9,484,638 |
2.44 |
- |
|
Blavatnik Len |
Affiliate of 10% Owner |
|
2022-01-19 |
4 |
B |
$14.70 |
$864,566 |
D/D |
58,818 |
9,480,023 |
2.44 |
- |
|
Blavatnik Len |
Affiliate of 10% Owner |
|
2022-01-18 |
4 |
B |
$14.26 |
$619,367 |
D/D |
43,429 |
9,421,205 |
2.44 |
- |
|
Blackman Samuel C. |
Chief Medical Officer |
|
2022-01-03 |
4 |
AS |
$16.95 |
$171,018 |
D/D |
(10,000) |
1,366,718 |
|
- |
|
Canaan Partners Xi Llc |
10% Owner |
|
2021-12-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(536,000) |
9,663,645 |
|
- |
|
Canaan Partners Xi Llc |
10% Owner |
|
2021-12-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(536,000) |
10,199,645 |
|
- |
|
Takeda Ventures, Inc. |
10% Owner |
|
2021-12-08 |
4 |
S |
$18.03 |
$1,989,394 |
I/I |
(110,338) |
6,120,124 |
|
- |
|
Takeda Ventures, Inc. |
10% Owner |
|
2021-12-07 |
4 |
S |
$18.43 |
$3,507,475 |
I/I |
(186,935) |
6,230,462 |
|
- |
|
Takeda Ventures, Inc. |
10% Owner |
|
2021-12-06 |
4 |
S |
$18.05 |
$1,763,341 |
I/I |
(97,692) |
6,417,397 |
|
- |
|
Takeda Ventures, Inc. |
10% Owner |
|
2021-12-03 |
4 |
S |
$18.47 |
$231,189 |
I/I |
(12,517) |
6,515,089 |
|
- |
|
Blackman Samuel C. |
Chief Medical Officer |
|
2021-12-01 |
4 |
AS |
$16.62 |
$172,242 |
D/D |
(10,000) |
1,376,718 |
|
- |
|
Blackman Samuel C. |
Chief Medical Officer |
|
2021-10-22 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,000,000 |
1,000,000 |
|
- |
|
Blackman Samuel C. |
Chief Medical Officer |
|
2021-10-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000,000 |
1,386,718 |
|
- |
|
Blavatnik Len |
Affiliate of 10% Owner |
|
2021-06-01 |
4 |
B |
$16.00 |
$14,000,000 |
D/D |
875,000 |
9,377,776 |
2.44 |
- |
|
Blavatnik Len |
Affiliate of 10% Owner |
|
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,502,776 |
8,502,776 |
|
- |
|
Papanek Julie |
Director |
|
2021-06-01 |
4 |
B |
$16.00 |
$208,000 |
I/I |
13,000 |
10,735,645 |
2.1 |
- |
|
Papanek Julie |
Director |
|
2021-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
7,476,776 |
10,722,645 |
|
- |
|
Atlas Venture Associates Xi, Llc |
10% Owner |
|
2021-06-01 |
4 |
B |
$16.00 |
$8,000,000 |
I/I |
500,000 |
250,000 |
1.5 |
- |
|
Atlas Venture Associates Xi, Llc |
10% Owner |
|
2021-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
8,502,776 |
741,396 |
|
- |
|
Canaan Partners Xi Llc |
10% Owner |
|
2021-06-01 |
4 |
B |
$16.00 |
$208,000 |
D/D |
13,000 |
10,735,645 |
2.45 |
- |
|
Canaan Partners Xi Llc |
10% Owner |
|
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,476,776 |
10,722,645 |
|
- |
|
Becker Daniel J. |
Director |
|
2021-06-01 |
4 |
B |
$16.00 |
$80,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
Josey John A. |
Director |
|
2021-06-01 |
4 |
B |
$16.00 |
$112,000 |
D/D |
7,000 |
72,292 |
2.39 |
- |
|
York Charles N Ii |
COO, CFO and SecretaryOfficer |
|
2021-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
337,560 |
|
- |
|
Josey John A. |
Director |
|
2021-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
65,292 |
|
- |
|
183 Records found
|
|
Page 7 of 8 |
|
|